Xavo is a software company with a clear focus on providing remarkable value to Biopharma R&D through Software-as-a-Service. Founded in 2000, Xavo has introduced the SaaS product Xavo R3, reimagining the approach to addressing the strategic challenge in the Biopharma R&D Sample Management realm. The company aims to optimize the fulfillment of changing assay and material demands based on finite lab capacity and inventory. With its innovative product, Xavo R3, Xavo aims to assist Sample Management groups in consistently delivering the right material in the right format, meeting the recipient's specifications, and ensuring on-time delivery every time, by providing the most effective combination of means. The company operates within the IT industry, with its headquarters' location not specified. Despite the lack of publicly disclosed details about the last investment and investors, Xavo's unwavering commitment to revolutionizing Biopharma R&D through technological advancements is evident in its groundbreaking solutions.
There is no investment information
No recent news or press coverage available for Xavo.